Abstract:Rickettsiosis includes a diversity of culture-negative non-specific systemic infections. Laboratory diagnosis of rickettsiosis is often not easy. In this 12-month study, six patients with a variety of rickettsia infections of the spotted fever group, typhus group and scrub typhus were diagnosed directly or indirectly by metagenomic next-generation sequencing (mNGS). The patient with Japanese spotted fever was rapidly made when mNGS analysis of the patient's blood revealed Rickettsia japonica sequences. For the two patients with Rickettsia felis chest infections, the bacterium was detected in the bronchoalveolar lavage of one case and lung biopsy of the other. Both patients had underlying malignancies, carcinoma of the breast and carcinoma of the lung respectively, and were on chemotherapy with immunosuppressive effect. For the remaining three patients who presented over a period of 13 weeks, all had fever, headache and the typical eschar. They also had increased serum transaminases and responded promptly to doxycycline. However, the Weil-Felix test results of all three patients were negative. Since we considered the three cases typical of rickettsiosis, we submitted their serum samples for mNGS analysis. Results showed that Orientia tsutsugamushi sequences were present in the serum of one case. In view of the positive mNGS results, we repeated the Weil-Felix test for the residual sera of all three patients and it revealed that those of the other two cases showed OX-19 titers of 1:640 and 1:160 respectively, inferring that these two patients probably had rickettsiosis of the typhus group. As for the patient positive for O . tsutsugamushi sequences, we also detected IgM for O . tsutsugamushi in the serum, which double confirmed that it was a case of scrub typhus. mNGS is an important molecular tool and can complement serology for laboratory diagnosis of rickettsiosis. Rickettsiosis includes a diversity of systemic infections presented with non-specific symptoms. Laboratory diagnosis of rickettsiosis is often not easy. In this 12-month study, six patients with a variety of rickettsia infections were diagnosed directly or indirectly by metagenomic next-generation sequencing (mNGS). These include one patient with Japanese spotted fever in whom Rickettsia japonica sequences were detected in blood, two patients with Rickettsia felis chest infections in whom R . felis sequences were detected in respiratory samples, one patient with scrub typhus in whom Orientia tsutsugamushi sequences were detected in serum, and two patients with rickettsiosis of the typhus group. In particular, the last three patients had initial false-negative Weil-Felix test results performed in a central reference laboratory but the diagnosis of rickettsiosis was subsequently confirmed by mNGS and repeated serology. mNGS is an important diagnostic tool for rickettsiosis and other difficult-to-diagnose systemic infections.

Detection of Severe Murine Typhus by Nanopore Targeted Sequencing, China.

Rapid Detection of Potential New Pathogens in Patient Using High -Throughput Sequencing

Metagenomic Next-Generation Sequencing Helped Diagnose Scrub Typhus Without Eschar: A Case Report.

The Application of Nanopore Targeted Sequencing for Pathogen Diagnosis in Bronchoalveolar Lavage Fluid of Patients with Pneumonia: a Prospective Multicenter Study.

Targeted nanopore sequencing using clinical specimens for the rapid diagnosis of extrapulmonary tuberculosis

Improved Targeting of the 16S Rdna Nanopore Sequencing Method Enables Rapid Pathogen Identification in Bacterial Pneumonia in Children.

Nanopore-Targeted Sequencing Improves the Diagnosis and Treatment of Patients with Serious Infections

Usefulness of next-generation sequencing for laboratory diagnosis of rickettsiosis

Clinical application of nanopore-targeted sequencing technology in bronchoalveolar lavage fluid from patients with pulmonary infections

Diagnosis and treatment of refractory infectious diseases using nanopore sequencing technology: Three case reports

The application of targeted nanopore sequencing for the identification of pathogens and resistance genes in lower respiratory tract infections

Clinical Performance of Nanopore Targeted Sequencing for Diagnosing Infectious Diseases

Diagnosing scrub typhus without eschar: a case report using metagenomic next-generation sequencing (mNGS)

Same Day Simultaneous Diagnosis of Bacterial and Fungal Infections in Clinical Practice by Nanopore Targeted Sequencing

Epidemiology of Murine Typhus in Taiwan from 2013 to 2020

Diagnosing and reintegrating traceability of infectious diseases via metagenomic next-generation sequencing: Study of a severe case of Rickettsia japonica infection

Nanopore sequencing for smear-negative pulmonary tuberculosis—a multicentre prospective study in China

Diagnosis of Acute Q Fever in a Patient by Using Metagenomic Next-Generation Sequencing: A Case Report

Rapid Detection and Identification of Infectious Pathogens Based on High-throughput Sequencing

Nanopore-based targeted next-generation sequencing of tissue samples for tuberculosis diagnosis

Evaluation of targeted sequencing for pathogen identification in bone and joint infections: a cohort study from China